20/20 Biolabs, Inc. AIDX
0.20 USD 0.00 (+1.43%)
Nov 9, 2026, 11:53 AM EST
0.1836 Day range 0.20
0.18 52-week range 50.00
- YTD
- -99.17%
- 1 year
- -99.17%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
| 2.05M | 1.75M | 1.42M | |
| 604.54K | 360.31K | 109.14K | |
| -3.33M | -5.66M | -6.36M | |
| -3.74M | -5.55M | -6.39M | |
| -0.76 | -1.16 | -1.34 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
| 1.03M | 1.78M | 4.09M | |
| 4.14M | 3.58M | 6.37M | |
| 4.16M | 2.08M | 2.08M | |
| 1.36M | 839.55K | 1.23M | |
| -19.23K | 1.51M | 4.29M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 |
|---|---|---|---|
| -1.92M | -2.60M | -4.48M | |
| 1.16M | 293.33K | -194.38K | |
| -758.02K | -2.31M | -4.72M |
